TRAF3 and its biological function

被引:0
|
作者
He, Jeannie Q. [1 ]
Oganesyan, Gagik [1 ]
Saha, Supriya K. [1 ]
Zarnegar, Brian [1 ]
Cheng, Genhong [1 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Med Scientist Training Program, Los Angeles, CA 90095 USA
来源
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor necrosis factor receptor associated factor 3 (TRAF3) is one of the most enigmatic members in the TRAF family that consists of six members, TRAF1 to 6. Despite its similarities with other TRAFs in terms of structure and protein-protein association, overexpression of TRAF3 does not induce activation of the commonly known TRAF-inducible signaling pathways, namely NF-kappa B and JNK. This lack of a simple functional assay in combination with the mysterious early lethality of the TRAF3-deficient mice has made the study of the biological function of TRAF3 challenging for almost ten years. Excitingly, TRAF3 has been identified recently to perform two seemingly distinct roles. Namely, TRAF3 functions as a negative regulator of the NF-kappa B pathway and separately, as a positive regulator of type I IFN production, placing itself as a critical regulator of both innate and adaptive immune responses.
引用
收藏
页码:48 / 59
页数:12
相关论文
共 50 条
  • [21] Expanding the clinical phenotype of TRAF3 haploinsufficiency syndrome
    Urban Vargas, Blanca Angelica
    Battle Maso, Laura
    Garcia Prat, Marina
    Parra Martinez, Alba
    Aguilo Cucurull, Aina
    Perurena Prieto, Janire
    Martinez Gallo, Monica
    Moushib, Laith
    Antolin Mate, Maria
    Riviere, Jacques G.
    Soler Palacin, Pere
    Dieli Crimi, Romina
    Franco Jarava, Clara
    Colobran, Roger
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1034 - 1034
  • [22] TRAF3 negatively regulates platelet activation and thrombosis
    Zhang, Rui
    Zhang, Guoying
    Xiang, Binggang
    Chen, Xiaofeng
    Tang, Lijang
    Shi, Shaojun
    Liu, Yani
    Ai, Xun
    Xie, Ping
    Li, Zhenyu
    SCIENTIFIC REPORTS, 2017, 7
  • [23] SUMOylation Is Required for Optimal TRAF3 Signaling Capacity
    Miliara, Sophia
    Gkouskou, Kalliopi K.
    Sharp, Tyson V.
    Eliopoulos, Aristides G.
    PLOS ONE, 2013, 8 (11):
  • [24] TRAF3 - A new regulator of type I Interferons
    Saha, Supriya K.
    Cheng, Genhong
    CELL CYCLE, 2006, 5 (08) : 804 - 807
  • [25] Roles of TRAF3 in T cells: many surprises
    Yi, Zuoan
    Wallis, Alicia M.
    Bishop, Gail A.
    CELL CYCLE, 2015, 14 (08) : 1156 - 1163
  • [26] Molecular cloning and expression analysis of TRAF3 in chicken
    Yang, H. L.
    Feng, Z. Q.
    Zeng, S. Q.
    Li, S. M.
    Zhu, Q.
    Liu, Y. P.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 4408 - 4419
  • [27] TRAF3: Uncovering the Real but Restricted Role in Human
    Bowie, Andrew G.
    IMMUNITY, 2010, 33 (03) : 293 - 295
  • [28] TRAF3, ubiquitination, and B-lymphocyte regulation
    Lin, Wai W.
    Hostager, Bruce S.
    Bishop, Gail A.
    IMMUNOLOGICAL REVIEWS, 2015, 266 (01) : 46 - 55
  • [29] TRAF3 negatively regulates platelet activation and thrombosis
    Rui Zhang
    Guoying Zhang
    Binggang Xiang
    Xiaofeng Chen
    Lijang Tang
    Shaojun Shi
    Yani Liu
    Xun Ai
    Ping Xie
    Zhenyu Li
    Scientific Reports, 7
  • [30] Diverse roles for TRAF2 and TRAF3 in NF-κB pathways
    Gardam, S
    Grech, AP
    Brink, RA
    TISSUE ANTIGENS, 2005, 66 (05): : 424 - 424